PUBLISHER: Grand View Research | PRODUCT CODE: 1813798
PUBLISHER: Grand View Research | PRODUCT CODE: 1813798
The global surgical robot procedures market size was estimated at USD 12.11 billion in 2024 and is projected to reach USD 50.63 billion by 2033, growing at a CAGR of 17.32% from 2025 to 2033.The convergence of advanced technology integration, broader procedural applicability, and rising institutional investment is driving the adoption of surgical robotics.
Hospitals are incorporating robotic systems across a wider range of specialties and procedure types, supported by growing clinical validation and operational efficiency. These developments are contributing to the standardization of surgical robotics within routine hospital workflows.In April 2024, Ohio State completed its first surgeries using the da Vinci 5 system, the latest-gen surgical robot with advanced tactile feedback and precision.
Rising demand for minimally invasive surgeries continues to be a primary catalyst for surgical robot adoption. Patients and providers alike are prioritizing procedures that offer reduced trauma, faster recovery, and fewer complications. Robotic systems enhance the precision and control required for these techniques, enabling surgeons to perform complex maneuvers through small incisions. In April 2025, Johnson & Johnson MedTech completed the first clinical cases using its OTTAVA robotic system for Roux-en-Y gastric bypass at Memorial Hermann-Texas Medical Center. The trial focuses on evaluating minimally invasive performance across general surgeries. Data will support a De Novo FDA submission for multi-procedure use.
Technological advancement is rapidly evolving the capabilities and appeal of surgical robotics. Integrations such as AI-assisted navigation, improved imaging, and ergonomic consoles are transforming surgical robots into fully integrated digital platforms. Modular architectures and specialty-specific toolkits have made systems more adaptable, while innovations in automation and analytics are improving intraoperative efficiency. In January 2025, Queen Elizabeth Hospital in King's Lynn, UK, introduced the USD 1.3M Versius surgical robot to treat cancer patients. Initially used for colorectal procedures, the system enables longer, complex surgeries with greater precision and comfort. The robot is expected to treat 100 patients in its first year and expand into urology and gynecology.
The expansion of procedural indications across multiple specialties is significantly accelerating system utilization. Robotic surgery, once limited to urology and gynecology, is now being deployed in general, bariatric, colorectal, orthopedic, and cardiothoracic procedures. As clinical evidence supports efficacy and payers broaden reimbursement, hospitals are leveraging robotic platforms across diverse departments. In June 2025, a surgeon in Orlando remotely performed a prostatectomy on a patient in Angola using a robotic system, marking the first FDA-approved human trial of transcontinental telesurgery. Conducted over 7,000 miles via fiber optic cables, the procedure showcased safe, real-time precision.
Global Surgical Robot Procedures Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global surgical robot procedures market report based on application, procedure type, procedure complexity, end-use, and region: